Bioinformatics market still exploding with growth; ALS trial database expanding;

> BCC Research projects the bioinformatics market to more than double in the coming years, jumping from almost $3.2 billion in 2012 to $7.5 billion by 2017, with demand for bioinformatics driven by a need to commercialize life sciences data in genomics and other fields. Item

> With clinical trial datasets from Novartis ($NVS) and others, an open access platform has emerged with data from more than 8,500 identity-free patient cases in an effort to support clinical studies of the complex neurodegenerative disease called amyotrophic lateral sclerosis. Article

> Cisco Canada ($CSCO) will award $2.1 million to McMaster University in Ontario to support research of integrated health biosystems and bioinformatics. Release

> Scale-up Systems has partnered with ScienView to provide Scale-up software for training and process development to the fast-growing pharma industry in China. Release

> TrialReach, a provider of online software for clinical trials, has raised £2 million from new investor Octopus and previous backer Amadeus Capital Partners. Item